Home › Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for Its New ...
 

Keywords :   


Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for Its New ...

2014-05-12 06:00:00| Industrial Newsroom - All News for Today

AUSTIN, Texas - Luminex Corporation (NASDAQ: LMNX) today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES&trade;. The assay will complement Luminex's growing portfolio of ASR and IVD products. Previously announced items in the five assay launch menu targeted for the ARIES system include: Flu A/B and RSV, HSV 1&2, Norovirus, and Clostridium difficile (C. diff).<br /> <br /> "ARIES represents the ...This story is related to the following:Test and Measuring InstrumentsSample Conditioning Equipment | Laboratory Equipment & Supplies

Tags: for new its group

Category:Industrial Goods and Services

Latest from this category

All news
01.07Mentorship in Motion
Industrial Goods and Services »
03.07Hurricane Beryl Public Advisory Number 20A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Genesus to restructure with Canada ZF Investments
03.07Global trade, domestic policy: What's at stake for pork industry
03.07Over 20,000 Tesco staff to split 30m from share schemes
03.07Ex-Post Office chair denies hiding key Horizon report
More »